Efficacy and safety of tyrosine kinase inhibitors (dasatinib, nilotinib) in the treatment of chronic phase chronic myeloid leukemia

Efficacy and safety of tyrosine kinase inhibitors (dasatinib, nilotinib) in the treatment of chronic phase chronic myeloid leukemia

Current treatment options for chronic myeloid leukemia (CML) with imatinib allowed achieving long-term progression-free and overall survival and improved patient quality of life. In cases of imatinib resistance therapy with second-generation tyrosine kinases inhibitors – dasatinib and nilotinib – is...

Full description

Saved in:
Bibliographic Details
Main Authors: E. G. Lomaia, E. G. Romanova, E. I. Sbityakova, A. Yu. Zaritskiy
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Онкогематология
Subjects:
chronic myeloid leukemia
dasatinib
nilotinib
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/30
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items